Detalhe da pesquisa
1.
Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma.
SAGE Open Med Case Rep
; 10: 2050313X221100407, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35619747
2.
Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient.
NPJ Precis Oncol
; 5(1): 5, 2021 Feb 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33580193
3.
Identification of the TP53 p.R337H Variant in Tumor Genomic Profiling Should Prompt Consideration of Germline Testing for Li-Fraumeni Syndrome.
JCO Glob Oncol
; 7: 1141-1150, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34270331
4.
Takotsubo syndrome induced by brachytherapy in a patient with endocervical adenocarcinoma.
Cardiooncology
; 6(1): 30, 2020 Dec 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33292719
5.
Circulating Tumour DNA Sequencing Identifies a Genetic Resistance-Gap in Colorectal Cancers with Acquired Resistance to EGFR-Antibodies and Chemotherapy.
Cancers (Basel)
; 12(12)2020 Dec 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33322618
6.
Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series.
Lung Cancer
; 139: 9-12, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31698333
7.
Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.
Case Rep Oncol Med
; 2018: 4290131, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29850323
8.
Successful Drug Rechallenge Following Severe Acute Alectinib-induced Interstitial Lung Disease in a Patient With Advanced ALK-rearranged Lung Adenocarcinoma.
Clin Lung Cancer
; 22(3): e481-e486, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32771343